Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow JNM on Twitter
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Subscribe to our RSS feeds
Meeting ReportCardiovascular -> Clinical Science

99mTc-Pyrophosphate Scintigraphy for the Diagnosis of ATTR Cardiac Amyloidosis: Early Phase Planar and SPECT Images versus Late Phase SPECT Images

Claudine Regis, Daniel Juneau, Patrick Martineau, Jean Gregoire, Gad Abikhzer, Francois Harel and Matthieu Pelletier-Galarneau
Journal of Nuclear Medicine May 2020, 61 (supplement 1) 666;
Claudine Regis
1Centre Hospitalier de l’Universite de Montreal Montreal QC Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Daniel Juneau
2Centre Hospitalier de l'Universite de Montreal Montreal QC Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Patrick Martineau
3Health Sciences Centre Winnipeg MB Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jean Gregoire
4Institut de Cardiologie de Montreal Montreal QC Canada
6Institut de Cardiologie de Montreal Montreal QC Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gad Abikhzer
5Jewish General Hospital Montreal QC
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Francois Harel
4Institut de Cardiologie de Montreal Montreal QC Canada
6Institut de Cardiologie de Montreal Montreal QC Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Matthieu Pelletier-Galarneau
4Institut de Cardiologie de Montreal Montreal QC Canada
6Institut de Cardiologie de Montreal Montreal QC Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
Loading

Abstract

666

Objectives: 99mTc-PYP bone scintigraphy can accurately diagnose transthyretin cardiac amyloidosis (ATTR-CA) and distinguish it from light-chain cardiac amyloidosis (AL-CA), with diffuse myocardial uptake of 99mTc-PYP being very specific for ATTR-CA. Two methods have been validated to analyze 99mTc-PYP scintigraphy: a quantitative heart-to-contralateral (H/CL) ratio calculated on planar images obtained 1h post injection, and a visual grading system based on planar or SPECT images obtained at 3h. The purpose of this multicentric study was to compare the 1h H/CL ratio to the visual grading system at 3h and to compare the visual grading system at 1h and 3h.

Methods: A total of 122 consecutive subjects, from 2 centers, who underwent both 1h and 3h planar and SPECT 99mTc-PYP imaging were retrospectively included. Circular regions of interest drawn over the heart and mirrored on the contralateral thorax were used to calculate the H/CL on 1h planar anterior images. Myocardial uptake intensity was compared to bone activity on both 1h and 3h SPECT images using the visual grading system. H/CL between 1.0 and 1.5 were considered equivocal for ATTR-CA, as was Grade 1 uptake on 3h imaging, as per current ASNC Practice Points. Agreement was evaluated using Cohen’s Kappa.

Results: 77 (63%), 10 (8%), 12 (10%), and 23 (19%) subjects had grade 0, 1, 2, and 3 myocardial uptake respectively at 3h. 10 (8%), 81 (66%) and 31 (25%) subjects had 1h H/CL ratio <1.0, between 1.0 and 1.5, and >1.5 respectively. Amongst those with H/CL between 1.0 and 1.5, 9 (11%) had grade 1 uptake at 3h while 67 (83%) had grade 0 and 5 (6%) and grade 2 or 3. The proportion of equivocal studies was significantly less when using the 3h grade compared to the H/CL method (p<0.0001). For two subjects, 3h grading and H/CL yielded discordant results; one had biopsy proven ATTR-CA with a H/CL of 0.91 and a grade 2 uptake while the other had biopsy proven AL-CA with a H/CL of 1.96 and a grade 0 uptake. Uptake grade was the same at 1h and at 3h on SPECT imaging in most patients, with 5 subjects having different grading at 1h and 3h. One subject had grade 1 uptake at 1h and grade 0 at 3h, 3 had grade 3 uptake at 1h and grade 2 at 3h, and 1 had grade 2 uptake at 1h and grade 3 at 3h. The agreement between uptake grade at 1h and at 3h was 99% when combining grade 2 and 3 (both considered positive for ATTR-CA as per current ASNC Practice Points).

Conclusions: A significant proportion of PYP scans yielded equivocal H/CL on 1h imaging, with significantly fewer equivocal results using the visual grading system on SPECT images at 3h, which in turn seems very comparable to the visual grading system on SPECT images at 1h. These results indicate that the use of 1h imaging H/CL alone, with current ASNC Practice Points interpretation thresholds, may lead to high proportion of equivocal studies, and 3h imaging remains necessary in a large proportion of patients.

Figure
  • Download figure
  • Open in new tab
  • Download powerpoint
Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 61, Issue supplement 1
May 1, 2020
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
99mTc-Pyrophosphate Scintigraphy for the Diagnosis of ATTR Cardiac Amyloidosis: Early Phase Planar and SPECT Images versus Late Phase SPECT Images
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
99mTc-Pyrophosphate Scintigraphy for the Diagnosis of ATTR Cardiac Amyloidosis: Early Phase Planar and SPECT Images versus Late Phase SPECT Images
Claudine Regis, Daniel Juneau, Patrick Martineau, Jean Gregoire, Gad Abikhzer, Francois Harel, Matthieu Pelletier-Galarneau
Journal of Nuclear Medicine May 2020, 61 (supplement 1) 666;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
99mTc-Pyrophosphate Scintigraphy for the Diagnosis of ATTR Cardiac Amyloidosis: Early Phase Planar and SPECT Images versus Late Phase SPECT Images
Claudine Regis, Daniel Juneau, Patrick Martineau, Jean Gregoire, Gad Abikhzer, Francois Harel, Matthieu Pelletier-Galarneau
Journal of Nuclear Medicine May 2020, 61 (supplement 1) 666;
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Figures & Data
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Cardiovascular -> Clinical Science

  • The impact of overweight and obesity on Chinese coronary microvascular function by using quantitative 13N-ammonia PET/CT
  • FDG-PET CT for the evaluation of native valve endocarditis
Show more Cardiovascular -> Clinical Science

Diagnostic and Prognostic Advances in Cardiac Radionuclide and Hybrid Imaging

  • Quantitation of Ventricular Morphology Provides Incremental Prognostic Utility in Patients Undergoing SPECT MPI
  • Respiration-averaged CT versus standard CT attenuation maps for correction of the 18F-NaF uptake in hybrid PET/CT
  • Progression to overt Coronary artery disease in Patients with Diabetes Mellitus at High Coronary Risk: 5 year follow-up of the prospective multicenter BARDOT Trial.
Show more Diagnostic and Prognostic Advances in Cardiac Radionuclide and Hybrid Imaging

Similar Articles

SNMMI

© 2022 Journal of Nuclear Medicine

Powered by HighWire